Obesity, Metabolic syndrome and diabetic nephropathy

Contributions to Nephrology

Volumn 170, Issue , 2011, Pages 28-35

  Maric, Christine ^a   Hall, John E ^a  

^a UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMINURIA; ARTICLE; DIABETIC NEPHROPATHY; GLOMERULUS FILTRATION RATE; HUMAN; HYPERTENSION; METABOLIC SYNDROME X; OBESITY;

ALBUMINURIA; DIABETIC NEPHROPATHIES; GLOMERULAR FILTRATION RATE; HUMANS; HYPERTENSION; METABOLIC SYNDROME X; OBESITY;

EID: 84925947100     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000324941     Document Type: Article

References (33)

1. de Zeeuw D, Ramjit D, Zhang Z, Ribeiro AB, Kurokawa K, Lash JP, Chan J, Remuzzi G, Brenner BM, Shahinfar S: Renal risk and renoprotection among ethnic groups with type 2 diabetic nephropathy: A post hoc analysis of RENAAL. Kidney Int 2006;69: 1675-1682.
2. Remuzzi G, Macia M, Ruggenenti P: Prevention and treatment of diabetic renal disease in type 2 diabetes: The BENEDICT study. J Am Soc Nephrol 2006;17:S90-97.
3. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM: Prevalence of overweight and obesity in the United States, 1999-2004. JAMA 2006;295:1549-1555.
4. Thomson SC, Vallon V, Blantz RC: Kidney function in early diabetes: The tubular hypothesis of glomerular filtration. Am J Physiol Renal Physiol 2004;286: F8-F15. (Pubitemid 38045037)
5. Hostetter TH: Hyperfiltration and glomerulosclerosis. Semin Nephrol 2003;23:194-199. (Pubitemid 36397101)
6. Caramori ML, Mauer M: Diabetes and nephropathy. Curr Opin Nephrol Hypertens 2003;12:273-282. (Pubitemid 36578062)
7. Leon CA, Raij L: Interaction of haemodynamic and metabolic pathways in the genesis of diabetic nephropathy. J Hypertens 2005;23:1931-1937. (Pubitemid 41830382)
8. Hall JE, Jones DW, Kuo JJ, da Silva A, Tallam LS, Liu J: Impact of the obesity epidemic on hypertension and renal disease. Curr Hypertens Rep 2003;5:386-392. (Pubitemid 38898962)
9. Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM: Influence of weight reduction on blood pressure: A meta-analysis of randomized controlled trials. Hypertension 2003;42:878-884. (Pubitemid 37413724)
10. Garrison RJ, Kannel WB, Stokes J 3rd, Castelli WP: Incidence and precursors of hypertension in young adults: The Framingham Offspring Study. Prev Med 1987;16:235-251. (Pubitemid 17067798)
11. Kalantar-Zadeh K, Kopple JD: Obesity paradox in patients on maintenance dialysis. Contrib Nephrol 2006;151:57-69. (Pubitemid 44298224)
12. Hall JE, Henegar JR, Dwyer TM, Liu J, Da Silva AA, Kuo JJ, Tallam L: Is obesity a major cause of chronic kidney disease? Adv Ren Replace Ther 2004;11:41-54. (Pubitemid 38174673)
13. Henegar JR, Bigler SA, Henegar LK, Tyagi SC, Hall JE: Functional and structural changes in the kidney in the early stages of obesity. J Am Soc Nephrol 2001;12: 1211-1217. (Pubitemid 32472634)
14. do Carmo JM, Tallam LS, Roberts JV, Brandon EL, Biglane J, da Silva AA, Hall JE: Impact of obesity on renal structure and function in the presence and absence of hypertension: Evidence from melanocortin-4 receptor-deficient mice. Am J Physiol Regul Integr Comp Physiol 2009;297:R803-R812.
15. Van Buren PN, Toto R: Hypertension in diabetic nephropathy: Epidemiology, mechanisms, and management. Adv Chronic Kidney Dis 2011;18:28-41.
16. Mancia G: Effects of intensive blood pressure control in the management of patients with type 2 diabetes mellitus in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Circulation 2010;122: 847-849.
17. Chagnac A, Weinstein T, Herman M, Hirsh J, Gafter U, Ori Y: The effects of weight loss on renal function in patients with severe obesity. J Am Soc Nephrol 2003;14:1480-1486. (Pubitemid 36687049)
18. Hall JE: The kidney, hypertension, and obesity. Hypertension 2003;41:625-633. (Pubitemid 36314565)
19. Griffin KA, Kramer H, Bidani AK: Adverse renal consequences of obesity. Am J Physiol Renal Physiol 2008;294:F685-F696.
20. Yip JW, Jones SL, Wiseman MJ, Hill C, Viberti G: Glomerular hyperfiltration in the prediction of nephropathy in IDDM: A 10-year follow-up study. Diabetes 1996;45: 1729-1733. (Pubitemid 26398952)
21. Vallon V, Schroth J, Satriano J, Blantz RC, Thomson SC, Rieg T: Adenosine A(1) receptors determine glomerular hyperfiltration and the salt paradox in early streptozotocin diabetes mellitus. Nephron Physiol 2009;111:30-38.
22. Woods LL, Mizelle HL, Hall JE: Control of renal hemodynamics in hyperglycemia: Possible role of tubuloglomerular feedback. Am J Physiol 1987;252:F65-F73.
23. Persson P, Hansell P, Palm F: Tubular reabsorption and diabetes-induced glomerular hyperfiltration. Acta Physiol (Oxf) 2010;200:3-10.
24. Cherney DZ, Scholey JW, Miller JA: Insights into the regulation of renal hemodynamic function in diabetic mellitus. Curr Diabetes Rev 2008;4:280-290.
25. Carmines PK: The renal vascular response to diabetes. Curr Opin Nephrol Hypertens 2010;19:85-90.
26. Fried LF, Orchard TJ, Kasiske BL: Effect of lipid reduction on the progression of renal disease: A meta-analysis. Kidney Int 2001; 59:260-269. (Pubitemid 32055234)
27. Jauregui A, Mintz DH, Mundel P, Fornoni A: Role of altered insulin signaling pathways in the pathogenesis of podocyte malfunction and microalbuminuria. Curr Opin Nephrol Hypertens 2009;18:539-545.
28. de Boer IH, Sibley SD, Kestenbaum B, Sampson JN, Young B, Cleary PA, Steffes MW, Weiss NS, Brunzell JD: Central obesity, incident microalbuminuria, and change in creatinine clearance in the epidemiology of diabetes interventions and complications study. J Am Soc Nephrol 2007;18:235-243. (Pubitemid 46053436)
29. Eijkelkamp WB, Zhang Z, Remuzzi G, Parving HH, Cooper ME, Keane WF, Shahinfar S, Gleim GW, Weir MR, Brenner BM, de Zeeuw D: Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: Post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial. J Am Soc Nephrol 2007;18: 1540-1546. (Pubitemid 46717521)
30. Comper WD, Russo LM: The glomerular filter: An imperfect barrier is required for perfect renal function. Curr Opin Nephrol Hypertens 2009;18:336-342.
31. Rutledge JC, Ng KF, Aung HH, Wilson DW: Role of triglyceride-rich lipoproteins in diabetic nephropathy. Nat Rev Nephrol 2010;6: 361-370.
32. King GL: The role of inflammatory cytokines in diabetes and its complications. J Periodontol 2008;79:1527-1534.
33. Ziyadeh FN: Mediators of diabetic renal disease: The case for TGF-beta as the major mediator. J Am Soc Nephrol 2004;15: S55-S57. (Pubitemid 38018457)